Evidence map›Paper›PMID 36675082›Full record

ReviewInternational journal of molecular sciences2023

Distinguishing Plasmin-Generating Microvesicles: Tiny Messengers Involved in Fibrinolysis and Proteolysis.

Laurent Plawinski, Audrey Cras, José Rubicel Hernández Lopez, Aurora de la Peña, Angéline Van der Heyden, Catherine Belle, Florence Toti, Eduardo Anglés-Cano

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Peptidases: Role and Function in Health and Disease.International journal of molecular sciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Laurent PlawinskiUMR 5797 Laboratoire de Physique des deux infinis, Université de Bordeaux-CNRS, 33170 Bordeaux, France.
Audrey CrasAssistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis, Unité de Thérapie Cellulaire, 75610 Paris, France.
José Rubicel Hernández LopezDepartamento de Farmacologia, Facultad de Medicina & Departamento de Biologia Molécular, Universidad National Autonoma de Mexico, Instituto Nacional de Cardiologia, Mexico City 04510, Mexico.
Aurora de la PeñaDepartamento de Farmacologia, Facultad de Medicina & Departamento de Biologia Molécular, Universidad National Autonoma de Mexico, Instituto Nacional de Cardiologia, Mexico City 04510, Mexico.
Angéline Van der HeydenDepartment of Molecular Chemistry (DMC), Université Grenoble-Alpes, CNRS, UMR 5250, 38000 Grenoble, France.
Catherine BelleDepartment of Molecular Chemistry (DMC), Université Grenoble-Alpes, CNRS, UMR 5250, 38000 Grenoble, France.
Florence TotiUniversité de Strasbourg-INSERM, UMR 1260, Centre de Recherche en Biomédecine (CRBS), 67084 Strasbourg, France.ORCID 0000-0001-5843-2816
Eduardo Anglés-CanoUniversité Paris Cité, INSERM, Innovative Therapies in Haemostasis, 75013 Paris, France.ORCID 0000-0001-7891-3975
Centre National de la Recherche Scientifique · FRInserm · FRInstituto Nacional de Cardiología · MXAssistance Publique – Hôpitaux de Paris · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A number of stressors and inflammatory mediators (cytokines, proteases, oxidative stress mediators) released during inflammation or ischemia stimulate and activate cells in blood, the vessel wall or tissues. The most well-known functional and phenotypic responses of activated cells are (1) the immediate expression and/or release of stored or newly synthesized bioactive molecules, and (2) membrane blebbing followed by release of microvesicles. An ultimate response, namely the formation of extracellular traps by neutrophils (NETs), is outside the scope of this work. The main objective of this article is to provide an overview on the mechanism of plasminogen reception and activation at the surface of cell-derived microvesicles, new actors in fibrinolysis and proteolysis. The role of microvesicle-bound plasmin in pathological settings involving inflammation, atherosclerosis, angiogenesis, and tumour growth, remains to be investigated. Further studies are necessary to determine if profibrinolytic microvesicles are involved in a finely regulated equilibrium with pro-coagulant microvesicles, which ensures a balanced haemostasis, leading to the maintenance of vascular patency.

Indexed as

Cell-Derived MicroparticlesFibrinolysisPlasminogenProteolysisBlood VesselsFibrinolysinHumansInflammationFibrinolysinPlasminogenextracellular vesiclesfibrinolysis crosstalkmicrovesiclespericellular proteolysisplasminogentPAuPAzinc complexes

Identifiers

PMID36675082
PMCPMC9860915
OpenAlexW4315798102

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.